Literature DB >> 21276282

Population-based study on the prevalence of spirometric obstructive pattern in Porto, Portugal.

Joana Mascarenhas1, Helena Falcão, Patrícia Lourenço, Cristiana Paulo, Marta Patacho, Paulo Bettencourt, Ana Azevedo.   

Abstract

BACKGROUND: The diagnosis of obstructive lung disease (OLD) based on clinical grounds is challenging. There have been no population-based COPD studies that collected pulmonary function data in Portugal, a country in transition between phases 2 and 3 of the smoking epidemic.
OBJECTIVE: To estimate the prevalence of obstructive pattern on spirometry in a representative sample of adults from Porto, Portugal.
METHODS: We conducted a health survey between 2001 and 2003, and 758 participants ≥ 40 years old had reliable spirometry. We used a structured questionnaire to collect demographic, clinical, social, and behavioral data. Obstructive pattern was defined as FEV(1)/FVC < 70%. Logistic regression was performed to quantify the association between socio-demographic and clinical factors and outcome.
RESULTS: The participants' mean ± SD age was 58.5 ± 11.5 years, and 62% were women. The prevalence of spirometric obstructive pattern was 10.7%, 95% CI 8.6-13.1%; 13.4% in men, and 9.1% in women (P = .08). The age-adjusted odds ratios for cumulative smoking exposure of less than and more than 20 pack years, in comparison with never smokers, were 3.49 (95% CI 1.02-11.92) and 3.91 (95% CI 1.29-11.89) among men, and 1.47 (95% CI 0.53-4.08) and 2.68 (95% CI 1.07-6.68) among women, respectively. Previously diagnosed OLD was reported by 30.9% (95% CI 21.1-42.1%) of the participants with spirometric obstructive pattern. Spirometry confirmed the OLD diagnosis in 20.5% (95% CI 13.7-28.7%) of subjects who self-reported OLD (kappa = 0.14, 95% CI 0.07-0.20).
CONCLUSIONS: The prevalence of spirometric obstructive pattern was high. Considering Portugal's position in the smoking epidemic, together with the aging of the population, we can expect an increase in the prevalence of OLD in older people and in women. Our results confirm the limited validity of self-reported OLD in epidemiological studies.

Entities:  

Mesh:

Year:  2011        PMID: 21276282     DOI: 10.4187/respcare.00698

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  3 in total

1.  Greater Access to Long Acting Beta2 Agonists Is Associated with Less Hospital Admissions Due to COPD: A Longitudinal Nation-Wide Study.

Authors:  Eduardo Vieira Ponte; Álvaro A Cruz; Valmar Bião Lima; Rafael Stelmach; Giovanni Viegi
Journal:  Lung       Date:  2018-09-05       Impact factor: 2.584

2.  Geographical distribution of COPD prevalence in Europe, estimated by an inverse distance weighting interpolation technique.

Authors:  Ignacio Blanco; Isidro Diego; Patricia Bueno; Eloy Fernández; Francisco Casas-Maldonado; Cristina Esquinas; Joan B Soriano; Marc Miravitlles
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-12-21

Review 3.  Global and regional estimates of COPD prevalence: Systematic review and meta-analysis.

Authors:  Davies Adeloye; Stephen Chua; Chinwei Lee; Catriona Basquill; Angeliki Papana; Evropi Theodoratou; Harish Nair; Danijela Gasevic; Devi Sridhar; Harry Campbell; Kit Yee Chan; Aziz Sheikh; Igor Rudan
Journal:  J Glob Health       Date:  2015-12       Impact factor: 7.664

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.